GLICK GARY D has a total of 34 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are SIRTRIS PHARMACEUTICALS INC, JANUS BIOTHERAPEUTICS INC and FERROKIN BIOSCIENCES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 27 | |
#2 | WIPO (World Intellectual Property Organization) | 7 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Machines | |
#5 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Glick Gary D | 34 |
#2 | Van Huis Chad A | 3 |
#3 | Ney Gina | 3 |
#4 | Opipari Anthony W | 3 |
#5 | Van Huis Chad Alan | 3 |
#6 | Opipari Jr Anthony W | 2 |
#7 | Taylor Clarke Bentley | 2 |
#8 | Toogood Peter | 2 |
#9 | Toogood Peter Laurence | 2 |
#10 | Taylor Clarke B | 2 |
Publication | Filing date | Title |
---|---|---|
US2015031068A1 | Methods and compositions for detecting immune system activation | |
US2013324536A1 | Pyrazolyl guanidine F1F0-atpase inhibitors and therapeutic uses thereof | |
US2014088094A1 | N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease | |
WO2011062765A2 | 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties | |
US2012094982A1 | 1,4-benzodiazepinone compounds and their use in treating cancer | |
WO2010030891A2 | Aryl guanidine f1f0-atpase inhibitors and related methods | |
US2006025388A1 | Compositions and methods relating to novel compounds and targets thereof |